Source: EURLEX
Language: en
Format: md

Judgment of the General Court (First Chamber) of 28 June 2023 –  
UGA Nutraceuticals v EUIPO – BASF (OMEGOR VITALITY)

(Case T‑496/22) (
[1](#t-ECR_62022TJ0496_INF_EN_01-E0001)
)

(EU trade mark – Opposition proceedings – Application for the EU word mark OMEGOR VITALITY – Earlier EU figurative mark OMACOR – Relative ground for refusal – Likelihood of confusion – Article 8(1)(b) of Regulation (EC) No 207/2009 (now Article 8(1)(b) of Regulation (EU) 2017/1001))

| 1. | EU trade mark – Appeals procedure – Action before the EU judicature – Jurisdiction of the General Court – Alteration of a decision of EUIPO – Assessment in the light of the powers conferred on the Board of Appeal  (European Parliament and Council Regulation 2017/1001, Art. 72(3))  (see paragraph 13) |

| 2. | EU trade mark – Definition and acquisition of the EU trade mark – Relative grounds for refusal – Opposition by the proprietor of an identical or similar earlier mark registered in respect of identical or similar goods or services – Likelihood of confusion with the earlier mark – Criteria for assessment  (European Parliament and Council Regulation 2017/1001, Art. 8(1)(b))  (see paragraphs 19, 20, 78) |

| 3. | EU trade mark – Definition and acquisition of the EU trade mark – Relative grounds for refusal – Opposition by the proprietor of an identical or similar earlier mark registered in respect of identical or similar goods or services – Likelihood of confusion with the earlier mark – Assessment of the likelihood of confusion – Determination of the relevant public – Attention level of the public – Health products  (European Parliament and Council Regulation 2017/1001, Art. 8(1)(b))  (see paragraphs 22, 26, 27) |

| 4. | EU trade mark – Definition and acquisition of the EU trade mark – Relative grounds for refusal – Opposition by the proprietor of an identical or similar earlier mark registered in respect of identical or similar goods or services – Likelihood of confusion with the earlier mark – Word mark OMEGOR VITALITY and figurative mark OMACOR  (European Parliament and Council Regulation 2017/1001, Art. 8(1)(b))  (see paragraphs 28, 37, 43, 53, 60, 67, 70, 77, 84) |

| 5. | EU trade mark – Definition and acquisition of the EU trade mark – Relative grounds for refusal – Opposition by the proprietor of an identical or similar earlier mark registered in respect of identical or similar goods or services – Similarity between the goods or services in question – Criteria for assessment  (European Parliament and Council Regulation 2017/1001, Art. 8(1)(b))  (see paragraphs 29, 42) |

| 6. | EU trade mark – Decisions of EUIPO – Legality – EUIPO’s previous decision-making practice  (European Parliament and Council Regulation 2017/1001)  (see paragraphs 44, 64) |

| 7. | EU trade mark – Definition and acquisition of the EU trade mark – Relative grounds for refusal – Opposition by the proprietor of an identical or similar earlier mark registered in respect of identical or similar goods or services – Similarity of the marks concerned – Criteria for assessment  (European Parliament and Council Regulation 2017/1001, Art. 8(1)(b))  (see paragraphs 45, 50, 52) |

Operative part

The Court:

| 1. | Dismisses the action; |

| 2. | Orders UGA Nutraceuticals Srl and the European Union Intellectual Property Office (EUIPO) to bear their own costs. |

---

(
[1](#c-ECR_62022TJ0496_INF_EN_01-E0001)
) [OJ C 380, 3.10.2022](./../../../legal-content/EN/AUTO/?uri=OJ:C:2022:380:TOC).

[Top](#document1)